Your browser doesn't support javascript.
loading
Decoration of Burkholderia Hcp1 protein to virus-like particles as a vaccine delivery platform.
Khakhum, Nittaya; Baruch-Torres, Noe; Stockton, Jacob L; Chapartegui-González, Itziar; Badten, Alexander J; Adam, Awadalkareem; Wang, Tian; Huerta-Saquero, Alejandro; Yin, Y Whitney; Torres, Alfredo G.
  • Khakhum N; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Baruch-Torres N; Department of Biochemistry and Molecular Biology, Sealy Center for Structural Biology and Molecular Biophysics, Galveston, Texas, USA.
  • Stockton JL; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Chapartegui-González I; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Badten AJ; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Adam A; Institute for Translational Sciences, Galveston, Texas, USA.
  • Wang T; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Huerta-Saquero A; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Yin YW; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Torres AG; Centro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México, Ensenada, Baja California, Mexico.
Infect Immun ; 92(3): e0001924, 2024 Mar 12.
Article en En | MEDLINE | ID: mdl-38353543
ABSTRACT
Virus-like particles (VLPs) are protein-based nanoparticles frequently used as carriers in conjugate vaccine platforms. VLPs have been used to display foreign antigens for vaccination and to deliver immunotherapy against diseases. Hemolysin-coregulated proteins 1 (Hcp1) is a protein component of the Burkholderia type 6 secretion system, which participates in intracellular invasion and dissemination. This protein has been reported as a protective antigen and is used in multiple vaccine candidates with various platforms against melioidosis, a severe infectious disease caused by the intracellular pathogen Burkholderia pseudomallei. In this study, we used P22 VLPs as a surface platform for decoration with Hcp1 using chemical conjugation. C57BL/6 mice were intranasally immunized with three doses of either PBS, VLPs, or conjugated Hcp1-VLPs. Immunization with Hcp1-VLPs formulation induced Hcp1-specific IgG, IgG1, IgG2c, and IgA antibody responses. Furthermore, the serum from Hcp1-VLPs immunized mice enhanced the bacterial uptake and opsonophagocytosis by macrophages in the presence of complement. This study demonstrated an alternative strategy to develop a VLPs-based vaccine platform against Burkholderia species.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Burkholderia pseudomallei / Burkholderia Límite: Animals Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Burkholderia pseudomallei / Burkholderia Límite: Animals Idioma: En Año: 2024 Tipo del documento: Article